Arnicare Product Line Expands With New Homeopathic Arthritis Cream
Arnicare Arthritis Cream is supplied in a 2.5oz tube and retails for $17.99.
Diagnosis & Disease Information
Hidden Drugs Found in 3 Supplements Promoted for Joint Pain, Arthritis
Fast-Act Rheuma Capsule, New Fast-Act Rheumatism Capsule, and UA-Block contain active hidden drug ingredients not listed on the product label.
FDA Clears Implantable Shock Absorber to Treat Knee Osteoarthritis
The device is implanted subcutaneously during an outpatient-compatible procedure.
Idacio, a Citrate-Free Biosimilar to Humira, Gets FDA Approval
The approval for Idacio was based on a review of data that showed similar pharmacokinetics, efficacy, safety, and immunogenicity to the reference adalimumab product.
Significant Improvements Seen With Bimekizumab in Ankylosing Spondylitis Trial
The ongoing phase 3 BE MOBILE 2 study compared the efficacy and safety of bimekizumab to placebo in 332 adults with active ankylosing spondylitis.
Xeljanz/Xeljanz XR Approved for Active Ankylosing Spondylitis
The approval was based on data from a phase 3 study which evaluated tofacitinib in adults with active AS who had an inadequate response to at least 2 NSAIDs.
Stelara Approved for Pediatric Psoriatic Arthritis
The approval is supported by evidence from adequate and well-controlled studies of Stelara.
FDA to Review Biosimilar Hyrimoz High Concentration Formulation
The sBLA is supported by data from a phase 1 pharmacokinetics bridging study comparing Hyrimoz 50mg/mL and citrate-free Hyrimoz HCF.
Rinvoq Approved for Active Ankylosing Spondylitis
The approval was based on data from the phase 2/3 SELECT-AXIS 1 and the phase 3 SELECT-AXIS 2 trials.
FDA to Review Abrilada for Interchangeability With Humira
The PAS is supported by data from the REFLECTIONS B538-12 study, which assessed multiple switches between Abrilada and Humira, in addition to methotrexate, in adults with moderate to severe rheumatoid arthritis.
- Loading...
Loading...
Loading... 
Loading...